Dear dupa,

Calling all biopharma experts and insiders!

Endpoints is building a better way to take the industry’s temperature — the Biopharma Sentiment Index (BPSI) — and we need your input.

We’re conducting a brief survey (4 minutes or less) that tracks the mood across the industry — science, finance, hiring and regulation. Your answers will help feed the BPSI, a quarterly benchmark that Endpoints publishes for the field.

The BPSI provides a forward-looking measure of biopharma sentiment, modeled after the University of Michigan’s Consumer Confidence Index. The quarterly survey tracks mood shifts that can rapidly reshape investment and R&D priorities.

Individual responses are confidential; we only publish aggregate results. Respondents will be the first to receive a complimentary copy of the report.

Thanks for lending your perspective,

Tom Randall
VP Endpoints News, Head of Signal